摘要
背景和目的:硫氧还蛋白相互作用蛋白(TXNIP)也被称为硫氧还蛋白结合蛋白-2是一种普遍表达的蛋白质,其相互作用并负调节硫氧还蛋白(TXN)的表达和功能。在过去几年中,由于其广泛的功能影响了能量代谢的几个方面,TXNIP引起了相当大的关注。 TXNIP通过多效性作用,作为葡萄糖和脂质代谢的重要调节因子,包括调节β细胞功能,肝葡萄糖产生,外周葡萄糖摄取,脂肪形成和底物利用。动物模型中TXNIP的过度表达已被证明可诱导胰腺β细胞的凋亡,降低外周组织如骨骼肌和脂肪的胰岛素敏感性,并降低能量消耗。相反,TXNIP缺陷动物受到饮食诱导的胰岛素抵抗和2型糖尿病的保护。 总结:因此,目标TXNIP被认为提供新的治疗机会,并且TXNIP抑制剂有潜力成为治疗糖尿病的有力治疗工具。在这里,我们总结了我们对TXNIP生物学的了解的现状,突出了其在代谢调节中的作用,并提出了有助于未来研究利用TXNIP作为治疗靶点的关键问题。
关键词: 糖尿病,硫氧还蛋白系统,硫氧还蛋白相互作用蛋白,氧化应激,胰岛素抵抗,胰腺β细胞功能障碍,代谢稳态
图形摘要
Current Drug Targets
Title:TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Volume: 18 Issue: 9
关键词: 糖尿病,硫氧还蛋白系统,硫氧还蛋白相互作用蛋白,氧化应激,胰岛素抵抗,胰腺β细胞功能障碍,代谢稳态
摘要: Background & Objective: Thioredoxin-interacting protein (TXNIP) also known as thioredoxin binding protein-2 is a ubiquitously expressed protein that interacts and negatively regulates expression and function of Thioredoxin (TXN). Over the last few years, TXNIP has attracted considerable attention due to its wide-ranging functions impacting several aspects of energy metabolism. TXNIP acts as an important regulator of glucose and lipid metabolism through pleiotropic actions including regulation of β-cell function, hepatic glucose production, peripheral glucose uptake, adipogenesis, and substrate utilization. Overexpression of TXNIP in animal models has been shown to induce apoptosis of pancreatic β-cells, reduce insulin sensitivity in peripheral tissues like skeletal muscle and adipose, and decrease energy expenditure. On the contrary, TXNIP deficient animals are protected from diet induced insulin resistance and type 2 diabetes.
Summary: Consequently, targeting TXNIP is thought to offer novel therapeutic opportunity and TXNIP inhibitors have the potential to become a powerful therapeutic tool for the treatment of diabetes mellitus. Here we summarize the current state of our understanding of TXNIP biology, highlight its role in metabolic regulation and raise critical questions that could help future research to exploit TXNIP as a therapeutic target.Export Options
About this article
Cite this article as:
TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook, Current Drug Targets 2017; 18 (9) . https://dx.doi.org/10.2174/1389450118666170130145514
DOI https://dx.doi.org/10.2174/1389450118666170130145514 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Technological Innovations in Magnetic Resonance for Early Detection of Cardiovascular Diseases
Current Pharmaceutical Design Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database
Current Rheumatology Reviews Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Differential Contribution of Clinical Amounts of Acetaldehyde to Skeletal and Cardiac Muscle Dysfunction in Alcoholic Myopathy
Current Pharmaceutical Design Evaluation of the Antioxidant and Antidiabetic Potential of the Poly Herbal Formulation: Identification of Bioactive Factors
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-Diabetic Effects of Isolated Lipids from Natural Sources through Modulation of Angiogenesis
Current Molecular Pharmacology What Does a Pediatrician Need to Know About Chronic Diarrhea?
Current Pediatric Reviews Role of Autophagy in Alzheimer’s Disease
Current Enzyme Inhibition Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease
Current Signal Transduction Therapy Acute Kidney Injury in Pediatric Heart Failure
Current Cardiology Reviews Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design Hyperhomocysteinemia and Sudden Cardiac Death: Potential Arrhythmogenic Mechanisms
Current Vascular Pharmacology Targeting SUMOylation Cascade for Diabetes Management
Current Drug Targets Occurrence and Clinical Impact of Microembolic Signals (MES) in Patients with Chronic Cardiac Diseases and Atheroaortic Plaques - A Systematic Review
Current Vascular Pharmacology Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Eisenmenger Syndrome: Recent Advances in Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Hypertension in Patients with Severe Aortic Stenosis: Emphasis on Antihypertensive Treatment and the Risk of Syncope
Current Hypertension Reviews A Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)
Current Cardiology Reviews Emerging Potential of Natural Products as an Alternative Strategy to Pharmacological Agents Used Against Metabolic Disorders
Current Drug Metabolism